NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/20/2022
Back to search
Official data from USPTO
PHARMA SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
12/20/2022
Trademark type
Combined
Nice classes
35
Filing date
10/08/2021
Registration date
12/20/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/20/2022
Last transaction
12/20/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/31/2021
First use in commerce
07/31/2021
Drawing code
5
Owner type
03
Owner location
Penn Valley, PA, US
Examiner
DEFORD, JEFFREY S
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stacked stylized words "PHARMA SOLUTIONS" with a geometric design composed of interlocking right side up and upside-down letter P's and S's appearing to the left of the lettering.
Holders and representatives
Holders
Pharma Solutions USA, Inc.
Representatives
BRETT A. SCHATZ WOOD HERRON & EVANS LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business servicesconsultation in the field of state and federal drug and device supply chain compliance solutions; Business servicesproviding state and federal drug and device supply chain compliance solutions
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/04/2022
PUBO
PUBLISHED FOR OPPOSITION
10/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/30/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
08/30/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/30/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
08/30/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/30/2022
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
07/27/2022
GPRA
PRIORITY ACTION E-MAILED
07/27/2022
CPRA
PRIORITY ACTION WRITTEN
07/27/2022
DOCK
ASSIGNED TO EXAMINER
07/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/01/2021
NWAP
NEW APPLICATION ENTERED
10/12/2021
Continuous trademark protection
Get notified about every new filing that threatens PHARMA SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.